0000950170-24-016462.txt : 20240216 0000950170-24-016462.hdr.sgml : 20240216 20240216164302 ACCESSION NUMBER: 0000950170-24-016462 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240215 FILED AS OF DATE: 20240216 DATE AS OF CHANGE: 20240216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOOD JENNIFER L CENTRAL INDEX KEY: 0001229245 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38886 FILM NUMBER: 24649058 MAIL ADDRESS: STREET 1: 15 GREAT RING ROAD CITY: SANDY HOOK STATE: CT ZIP: 06482 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Trevi Therapeutics, Inc. CENTRAL INDEX KEY: 0001563880 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 450834299 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 195 CHURCH STREET STREET 2: 14TH FLOOR CITY: NEW HAVEN STATE: CT ZIP: 06510 BUSINESS PHONE: 203-304-2499 MAIL ADDRESS: STREET 1: 195 CHURCH STREET STREET 2: 14TH FLOOR CITY: NEW HAVEN STATE: CT ZIP: 06510 4 1 ownership.xml 4 X0508 4 2024-02-15 0001563880 Trevi Therapeutics, Inc. TRVI 0001229245 GOOD JENNIFER L C/O TREVI THERAPEUTICS, INC. 195 CHURCH STREET, 16TH FLOOR NEW HAVEN CT 06510 true true false false President & CEO false Stock Option (right to buy) 2.38 2024-02-15 4 A false 630000 0.00 A 2034-02-14 Common Stock 630000 630000 D This option was granted on February 15, 2024. The 630,000 shares of common stock underlying the option are scheduled to vest as to 25% of the shares on February 15, 2025 and as to the remaining 75% of the shares in equal monthly installments thereafter through February 15, 2028. /s/ Christopher Galletta, attorney-in-fact 2024-02-16